Skip to content

The effect of substance X blended bread on postprandial blood glucose level in healthy human subjects.

The effect of substance X blended bread on postprandial blood glucose level in healthy human subjects. - The effect of substance X blended bread on postprandial blood glucose level.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031038
Enrollment
30
Registered
2018-01-30
Start date
2018-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Test bread (substance X blended), strawberry jam and black tea (single ingestion) -&gt
Placebo bread (substance X non-blended), strawberry jam and black tea (single ingestion) Placebo bread (substance X non-blended), strawberry jam and black tea (single ingestion) -&gt
Test bread (substance X blended), strawberry jam and black tea (single ingestion)

Sponsors

Hayashibara CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy volunteers. 2)Employees at the Hayashibara CO., LTD. 3)Subjects without any allergy symptoms related in the study. 4)Subjects who signed the informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1)Subjects with medical history of severe disorders. 2)Subjects with continuous medical treatment for chronic disease. 3)Pregnant or have possibility to become pregnant during the study or lactating women. 4)Subjects regularly using medicine, supplements and/or functional foods (including Food for Specified Health Uses [FOSHU]) that may affect the results of the study. 5)Subjects work shifts. 6)Subjects who blood glucose levels are fasting < 60 mg/dL or >= 126 mg/dL, 120 minutes postprandial >= 189 mg/dL and random >= 270 mg/dL. (as the level of blood glucose from a capillary) 7)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.

Design outcomes

Primary

MeasureTime frame
Blood glucose levels

Countries

Japan

Contacts

Public ContactYuki Ishida

Hayashibara CO., LTD. R & D Division, Development Unit

yuki.ishida@hb.nagase.co.jp086-276-3141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026